Liver-derived MSCs, such as Promethera Biosciences’ HepaStem, emerged from these studies with an immunogenic advantage. HepaStem is an allogeneic cell therapy based on liver-derived progenitor ...

Hepatocytes, as the most abundant cell type in liver, are a potent source of fibrogenic lipid peroxides in inflammatory liver diseases. Platelets are a potent source of growth factors, and are ...

Obesity boosts pro-inflammatory helper T type 1 (Th1) cells ... translocation into the liver, leading to VAT neutrophil ...